Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway

An intermittent fasting (IF) regimen has been shown to protect against metabolic dysfunction-associated steatohepatitis (MASH). However, the precise mechanism remains unclear. Here, we explored how IF reduced hepatic lipid accumulation, inflammation, and fibrosis in mice with MASH. The mice were fed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyung Eun, Shin, Hyun Joo, Ju, Yeajin, Jung, Youngae, An, Hyeong Seok, Lee, So Jeong, Jeong, Eun Ae, Lee, Jaewoong, Hwang, Geum-Sook, Roh, Gu Seob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649202/
https://www.ncbi.nlm.nih.gov/pubmed/37960230
http://dx.doi.org/10.3390/nu15214574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649202/
https://www.ncbi.nlm.nih.gov/pubmed/37960230
http://dx.doi.org/10.3390/nu15214574

Ejemplares similares